HMGB1 and cystic fibrosis: Emerging evidence indicates that HMGB1, a pluripotent mediator, contributes to many fibrotic diseases such as CF, liver fibrosis and progressive PF, indicating that HMGB1 may be a promising therapeutic target for such diseases.